Answer:
<h2>As transcription and translation occurs in different location in eukaryotes, while in prokaryotes, both the processes occurs at same location, post-transcriptional processing in eukaryotes. </h2>
Explanation:
The transcription and translation occurs in different location in eukaryotes, while in prokaryotes, both the processes occurs at same location and can be co-translation.
As, in eukaryotes, the transcription occurs in the nucleus and then this transcript have to move in the cytoplasm to translation, so before reaching in the cytoplasm, various modifications occur in this transcript known as post transcriptional modification or processing ( include 5' capping, 3' poly-adenylation and RNA splicing).
As, in prokaryotes, both transcription and translation occur at same place so there is no time for modification for transcript because translation starts as the transcription is still going on.
Bb × bb = 2 Bb : 2 bb = 1 Bb : 1 bb
Thus, the phenotypic ratio would be 1 Dominant Phenotype : 1 Recessive Phenotype.
Answer:
Changing the allosteric site would definitely impact the sensitivity of the blocker, and we can not understand precisely how it is owing to our lack of awareness of the specific adjustments and the FX11 layout.
Explanation:
The move would most likely reduce affinity, and FX11 will no longer be as successful as inhibiting C. Growth of parvum. An inhibitor may reach an allosteric site since the site has some sizes and operational classes that precisely match the shape and operational categories of the inhibitor, which is how the association is obtained if the shape is modified and the inclination is affected.
Such chemicals can be used as human drugs because the mechanism we 're disrupting isn't that normal in human cells, we 're talking about lactic fermentation. C.parvum is a parasite that is present in the digestive tract, and these areas do not appear to experience aerobic glycolysis. The material that undergoes this process under other conditions is muscle tissue. It is possible that the absorbed drug can penetrate the bloodstream and touch other organs, and we would recommend that clinicians avoid exercise during this drug therapy.
The answer is the sphenoid bone
Answer: Out of them, the odd one out is increased flow urine because the symptom is little or no urine. Hope that helps
